Amneal Pharmaceuticals, Inc. financial data

Symbol
AMRX on Nasdaq
Location
Bridgewater, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 27 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 174% % 22%
Quick Ratio 62% % 9.7%
Return On Equity -68% % -147%
Return On Assets 2% %
Operating Margin 13% % 46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 314,629,101 shares 1.5%
Entity Public Float $1,700,000,000 USD 6.2%
Weighted Average Number of Shares Outstanding, Basic 313,367,000 shares 1.4%
Weighted Average Number of Shares Outstanding, Diluted 324,805,000 shares 5.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $3,018,760,000 USD 8%
Research and Development Expense $186,175,000 USD -2.4%
Operating Income (Loss) $394,096,000 USD 58%
Nonoperating Income (Expense) $254,887,000 USD 16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $139,209,000 USD
Income Tax Expense (Benefit) $11,276,000 USD -40%
Net Income (Loss) Attributable to Parent $72,057,000 USD
Earnings Per Share, Basic 0.23 USD/shares
Earnings Per Share, Diluted 0.22 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $282,029,000 USD 155%
Inventory, Net $606,302,000 USD -1%
Assets, Current $1,911,181,000 USD 20%
Property, Plant and Equipment, Net $442,950,000 USD 4.2%
Operating Lease, Right-of-Use Asset $54,048,000 USD 28%
Intangible Assets, Net (Excluding Goodwill) $563,498,000 USD -23%
Goodwill $595,470,000 USD -0.33%
Other Assets, Noncurrent $57,805,000 USD -3.9%
Assets $3,678,280,000 USD 5%
Accounts Payable, Current $266,358,000 USD 13%
Employee-related Liabilities, Current $63,899,000 USD -1.5%
Liabilities, Current $881,633,000 USD -22%
Accumulated Other Comprehensive Income (Loss), Net of Tax $110,729,000 USD -69%
Retained Earnings (Accumulated Deficit) $535,005,000 USD 12%
Stockholders' Equity Attributable to Parent $70,794,000 USD 35%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $71,329,000 USD 35%
Liabilities and Equity $3,678,280,000 USD 5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,408,000 USD
Net Cash Provided by (Used in) Financing Activities $39,166,000 USD -69%
Net Cash Provided by (Used in) Investing Activities $17,798,000 USD 9.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $50,026,000 USD -5.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $312,939,000 USD 164%
Interest Paid, Excluding Capitalized Interest, Operating Activities $56,323,000 USD -13%
Deferred Tax Assets, Valuation Allowance $586,573,000 USD -0.64%
Deferred Tax Assets, Gross $586,573,000 USD -0.64%
Operating Lease, Liability $58,801,000 USD 25%
Payments to Acquire Property, Plant, and Equipment $13,162,000 USD 43%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $26,838,000 USD
Lessee, Operating Lease, Liability, to be Paid $79,204,000 USD 35%
Property, Plant and Equipment, Gross $1,049,120,000 USD 6.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $15,019,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year One $16,941,000 USD 0.16%
Operating Lease, Weighted Average Discount Rate, Percent 0.101 pure 5.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $20,403,000 USD 74%
Lessee, Operating Lease, Liability, to be Paid, Year Three $12,813,000 USD 21%
Deferred Tax Assets, Operating Loss Carryforwards $48,410,000 USD 45%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2,000,000 shares 0%
Unrecognized Tax Benefits $4,026,000 USD 2.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $11,938,000 USD 46%
Additional Paid in Capital $571,794,000 USD 2.1%
Amortization of Intangible Assets $166,300,000 USD -4.2%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%